Abstract Details

Title Impact of race in ischemic stroke affecting young adults

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) P2 - Poster Session 2 (5:30 PM-6:30 PM)

Poster/Presentation
Number 3-013

Objective

To examine the impact of race on stroke mechanism and healthcare utilization in young adults with ischemic stroke.

Background Ischemic stroke in young adults is different from stroke in older population in mechanism and functional outcome. The effect of race is not well understood in this subset of stroke patients.

Design/Methods Institutional GWTG database and charts for years 2010-2017 were reviewed. Demographic, social, and clinical characteristics were compared among white, black and other races in a univariate analysis. TOAST criteria were used to categorize stroke mechanism.

Results

A total of 173 patients were identified, of which 119 were white, 34 black and 20 other races. Black patients had higher rate of hypertension (65% vs 27%, p<0.001) and a non-significantly higher rates of diabetes (29% vs 14%, p=0.079), smoking (62% vs 53%, p=0.089), and previous TIA/ stroke (32% vs 15%, p=0.068).

Black patients had a higher incidence of weakness as a presenting symptom (62% vs 37%, p=0.035), yet the median time from onset to ER arrival tended to be higher compared to whites (10.8 vs 5.5 hours, p=0.1). There was a trend towards higher utilization of EMS, lower rates of independent ambulation, and lower rates of discharge to home in black patients.

Stroke mechanism was significantly different by race with higher incidence of large as well as small vessel disease in blacks and higher incidence of cryptogenic strokes in whites (p=0.04).

Conclusions There is a significant impact of race on the mechanism of stroke in young as well as healthcare resources utilization.

Authors/Disclosures
Haitham Hussein, MD, FAAN (University of Minnesota Medical School) PRESENTER	Dr. Hussein has nothing to disclose.
Bhavani Kashyap, MBBS, PhD (HealthPartners Neuroscience Center)	Dr. Kashyap has nothing to disclose.
	No disclosure on file
	No disclosure on file
Sally I. Othman	No disclosure on file
	No disclosure on file
Leah R. Hanson, PhD (Health Partners Neuroscience Center)	The institution of Dr. Hanson has received research support from NIA. The institution of Dr. Hanson has received research support from Merck Foundation. The institution of Dr. Hanson has received research support from Eagle Pharmaceuticals. The institution of Dr. Hanson has received research support from Research Grow Lab. The institution of Dr. Hanson has received research support from State of Minnesota. Dr. Hanson has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file

��ɫ��

��ɫ��